Skip to main content

CombiMatrix to Develop Alzheimer s Diagnostic with Case Western Researchers

NEW YORK, Feb. 23 (GenomeWeb News) - Acacia Research group CombiMatrix will collaborate with researchers at Case Western Reserve University to develop a diagnostic test for Alzheimer's disease, the company said today.

 

The university scientists, led by Mark Smith at the Department of Pathology, will use CombiMatrix's CustomArray microarray platform in their research.

 

CombiMatrix's platform uses electrochemically and independently addressable microelectrodes on semiconductor chips.

 

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.